Secondary Logo

Journal Logo

Most Popular Articles

Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment

Ball, Laura J.; Venner, Colin; Tirona, Rommel G.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(4):e127-e134, August 1, 2019.

Evaluation of the Performance of OraQuick Rapid HIV-1/2 Test Among Decedents in Kisumu, Kenya

Opollo, Valarie; Nyakeriga, Emmanuel; Kingwara, Leonard; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(3):282-287, March 1, 2022.

Addressing Racism's Role in the US HIV Epidemic: Qualitative Findings From Three Ending the HIV Epidemic Prevention Projects

Harrison, Sayward E.; Muessig, Kathryn; Poteat, Tonia; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S46-S55, July 1, 2022.

Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review

Li, Dennis H.; Benbow, Nanette; Keiser, Brennan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S235-S246, July 1, 2022.

Reducing Intersecting Stigmas in HIV Service Organizations: An Implementation Science Model

Rodriguez-Hart, Cristina; Mackson, Grace; Belanger, Dan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S215-S225, July 1, 2022.

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Rizzardini, Giuliano; Overton, Edgar T.; Orkin, Chloe; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(4):498-506, December 1, 2020.

Early Diagnosis of HIV-1 and HIV-2 Using Cobas HIV-1/HIV-2 Qualitative Test: A Novel Qualitative Nucleic Acid Amplification Test for Plasma, Serum, and Dried Blood Spot Specimens

Hans, Lucia; Allmen, Nicole von; Edelmann, Anke; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(5):1187-1195, August 15, 2021.

Feasibility and Acceptability of HIV Self-Test Kit Distribution Through PrEP Clients' Social and Sexual Networks to Increase HIV Testing and PrEP Information

King, Katherine; Balan, Shuba; Kanamori, Mariano; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S105-S113, July 1, 2022.

Supporting the Growth of Domestic HIV Implementation Research in the United States Through Coordination, Consultation, and Collaboration: How We Got Here and Where We Are Headed

Mustanski, Brian; Smith, Justin D.; Keiser, Brennan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S1-S8, July 1, 2022.

Brief Report: Bictegravir/Emtricitabine/Tenofovir Alafenamide Efficacy in Participants With Preexisting Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials

D'Antoni, Michelle L.; Andreatta, Kristen; Acosta, Rima; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(4):433-440, April 1, 2022.

Development of an Implementation Facilitation Strategy to Link Mental Health Screening and eHealth Intervention for Clients in Ryan White–Funded Clinics in Chicago

Stump, Tammy K.; Ethier, Kristen; Hirschhorn, Lisa R.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S197-S205, July 1, 2022.

Comprehensive Process Mapping and Qualitative Interviews to Inform Implementation of Rapid Linkage to HIV Care Programs in a Mid-Sized Urban Setting in the Southern United States

Pettit, April C.; Pichon, Latrice C.; Ahonkhai, Aima A.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S56-S64, July 1, 2022.

Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes

Moorhouse, Michelle; Maartens, Gary; Venter, Willem Daniel Francois; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 80(1):73-78, January 1, 2019.

Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research

Johnson, Amy K.; Pyra, Maria; Devlin, Samantha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S141-S148, July 1, 2022.

The Shang Ring Device for Adult Male Circumcision: A Proof of Concept Study in Kenya

Barone, Mark A; Ndede, Frederick; Li, Philip S; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(1):e7-e12, May 1, 2011.

COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV

Bogart, Laura M.; Ojikutu, Bisola O.; Tyagi, Keshav; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 86(2):200-207, February 1, 2021.

Explorations of the Role of Digital Technology in HIV-Related Implementation Research: Case Comparisons of Five Ending the HIV Epidemic Supplement Awards

Jones, Jeb; Knox, Justin; Meanley, Steven; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S226-S234, July 1, 2022.

Brief Report: Recent HIV Infection Surveillance in Routine HIV Testing in Nairobi, Kenya: A Feasibility Study

Welty, Susie; Motoku, John; Muriithi, Chris; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 84(1):5-9, May 1, 2020.

Strengthening HIV Prevention Services Through an Implementation Science Approach: Perspectives From the HIV Testers in Philadelphia

Wood, Sarah M.; Meanley, Steven; Bonett, Stephen; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S90-S97, July 1, 2022.

Identification of Determinants and Implementation Strategies to Increase PrEP Uptake Among Black Same Gender–Loving Men in Mecklenburg County, North Carolina: The PrEP-MECK Study

Corneli, Amy; Perry, Brian; Wilson, Johnny; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S149-S160, July 1, 2022.

Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia

Ruiz, Monica S.; O'Rourke, Allison; Allen, Sean T.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 82:S148-S154, December 1, 2019.

Data Velocity in HIV-Related Implementation Research: Estimating Time From Funding to Publication

Schwartz, Sheree R.; Chavez Ortiz, Joel; Smith, Justin D.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S32-S40, July 1, 2022.

Acceptability and Appropriateness of Digital PrEP Interventions for Black and Latina Cisgender Women: Perspectives From Service Providers in Los Angeles County

Üsküp, Dilara K.; Nieto, Omar; Rosenberg-Carlson, Elena; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S134-S140, July 1, 2022.

Costs and Cost-Effectiveness of the Patient-Centered HIV Care Model: A Collaboration Between Community-Based Pharmacists and Primary Medical Providers

Shrestha, Ram K.; Schommer, Jon C.; Taitel, Michael S.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(3):e48-e54, November 01, 2020.

Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials

Cahn, Pedro; Madero, Juan Sierra; Arribas, José R.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 83(3):310-318, March 1, 2020.

Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya

Haberer, Jessica E.; Mugo, Nelly; Bukusi, Elizabeth Ann; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(3):251-260, March 1, 2022.

Safe Spaces 4 Sexual Health: A Status-Neutral, Mobile Van, HIV/STI Testing Intervention Using Online Outreach to Reach MSM at High Risk for HIV Acquisition or Transmission

Fields, Errol L.; Thornton, Nicole; Huettner, Steven; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S84-S89, July 1, 2022.

Safety and Pharmacokinetics of Once-Daily Multiple-Dose Administration of Islatravir in Adults Without HIV

Matthews, Randolph P.; Jackson Rudd, Deanne; Zhang, Saijuan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 88(3):314-321, November 1, 2021.

A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies

Curno, Mirjam J.; Rossi, Samuela; Hodges-Mameletzis, Ioannis; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 71(2):181-188, February 1, 2016.

Multilevel Determinants of Rapid Antiretroviral Treatment Implementation and Demand in Miami-Dade County

Harkness, Audrey; Wawrzyniak, Andrew J.; Kolber, Michael A.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S177-S189, July 1, 2022.

Using Implementation Mapping to Ensure the Success of PrEP Optimization Through Enhanced Continuum Tracking (PrOTECT) AL-A Structural Intervention to Track the Statewide PrEP Care Continuum in Alabama

Creger, Thomas; Burgan, Kaylee; Turner, Wesli H.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S161-S166, July 1, 2022.

PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation

Giguère, Katia; Béhanzin, Luc; Guédou, Fernand A.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(3):257-264, November 1, 2019.

Men's Understanding of and Experiences During the Postcircumcision Abstinence Period: Results From a Field Study of ShangRing Circumcision During Routine Clinical Services in Kenya and Zambia

Barone, Mark A.; Li, Philip S.; Zulu, Robert; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 72:S18-S23, June 1, 2016.

The Setting-Intervention Fit of Nine Evidence-Based Interventions for Substance Use Disorders Within HIV Service Organizations Across the United States: Results of a National Stakeholder-Engaged Real-Time Delphi Study

Garner, Bryan R.; Knudsen, Hannah K.; Zulkiewicz, Brittany A.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S206-S214, July 1, 2022.

Effect of Digital Adherence Tools on Adherence to Antiretroviral Treatment Among Adults Living With HIV in Kilimanjaro, Tanzania: A Randomized Controlled Trial

Sumari-de Boer, I. Marion; Ngowi, Kennedy M.; Sonda, Tolbert B.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(5):1136-1144, August 15, 2021.

Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis

Eron, Joseph; Hung, Chien-Ching; Baril, Jean-Guy; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 84(1):60-65, May 1, 2020.

Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy: A Randomized Phase 2 Study

Sax, Paul E.; Zolopa, Andrew; Brar, Indira; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(1):52-58, September 1, 2014.

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial

Johnson, Margaret; Kumar, Princy; Molina, Jean-Michel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(4):463-472, August 1, 2019.

Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial

Kumar, Princy; Johnson, Margaret; Molina, Jean-Michel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(2):801-805, June 1, 2021.

Proyecto Compadre: Using Implementation Science to Tailor Peer Navigation for Latino Men in the US–Mexico Border Region

Tsuyuki, Kiyomi; Stockman, Jamila K.; Stadnick, Nicole A.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(S1):S98-S104, July 1, 2022.

Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study

Bekker, Adrie; Rabie, Helena; Salvadori, Nicolas; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(3):324-331, March 1, 2022.

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study

Hagins, Debbie; Kumar, Princy; Saag, Michael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 88(1):86-95, September 1, 2021.

What Really Is a Concentrated HIV Epidemic and What Does It Mean for West and Central Africa? Insights From Mathematical Modeling

Boily, Marie-Claude; Pickles, Michael; Alary, Michel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 68:S74-S82, March 1, 2015.

Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin: Results of a Phase 1 Study Among Healthy Subjects

Dooley, Kelly E.; Sayre, Patrick; Borland, Julie; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(1):21-27, January 1, 2013.

How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis

Fearon, Elizabeth; Phillips, Andrew; Mtetwa, Sibongile; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(1):24-35, May 1, 2019.

Gamma Glutamyl Transferase Elevation in HIV/Hepatitis C Virus-Coinfected Patients During Interferon-Ribavirin Combination Therapy

Bani-Sadr, Firouzé; Lapidus, Nathanael; Rosenthal, Eric; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(4):429-430, April 2009.

HIV Infection and Its Association With an Excess Risk of Clinical Fractures: A Nationwide Case–Control Study

Prieto-Alhambra, Daniel; Güerri-Fernández, Robert; De Vries, Frank; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(1):90-95, May 1, 2014.

Show: